Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zynex, a provider of pain management systems and electrotherapy products for medical patients with functional disability, has received CE marking for its NeuroMove and TruWave devices for sales in Europe.
Subscribe to our email newsletter
Both NeuroMove and TruWave devices have previously received the FDA’s clearance for marketing in the US.
NeuroMove is marketed for stroke and spinal cord injury rehabilitation and TruWave is an electrotherapy device.
Thomas Sandgaard, CEO of Zynex, said: “The CE marking allows us to sell these products in the EU and we also anticipate it will help the process of regulatory approval in many other countries outside of Europe.”